Peetz Christopher's most recent trade in Arcutis Biotherapeutics Inc was a trade of 21,486 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc | Christopher Peetz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2026 | 21,486 | 21,486 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Christopher Peetz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2026 | 13,010 | 13,010 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Christopher Peetz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2026 | 4,315 | 4,315 (0%) | 0% | 0 | Common Stock | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 06 Jul 2026 | 20,000 | 214,309 (0%) | 0% | 2.9 | 58,720 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2026 | 20,000 | 108,487 | - | - | Employee Stock Option (right to buy) | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 121.65 per share. | 06 Jul 2026 | 12,134 | 202,175 (0%) | 0% | 121.6 | 1,476,101 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 122.34 per share. | 06 Jul 2026 | 4,181 | 197,994 (0%) | 0% | 122.3 | 511,504 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 123.74 per share. | 06 Jul 2026 | 1,975 | 196,019 (0%) | 0% | 123.7 | 244,387 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 124.79 per share. | 06 Jul 2026 | 1,710 | 194,309 (0%) | 0% | 124.8 | 213,391 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 01 Jun 2026 | 30,000 | 224,309 (0%) | 0% | 2.9 | 88,080 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2026 | 30,000 | 128,487 | - | - | Employee Stock Option (right to buy) | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 95.34 per share. | 01 Jun 2026 | 16,595 | 205,112 (0%) | 0% | 95.3 | 1,582,167 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 96.15 per share. | 01 Jun 2026 | 6,926 | 198,186 (0%) | 0% | 96.2 | 665,935 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 94.64 per share. | 01 Jun 2026 | 2,602 | 221,707 (0%) | 0% | 94.6 | 246,253 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 97.56 per share. | 01 Jun 2026 | 1,973 | 196,213 (0%) | 0% | 97.6 | 192,486 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 98.20 per share. | 01 Jun 2026 | 1,021 | 195,192 (0%) | 0% | 98.2 | 100,262 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 99.66 per share. | 01 Jun 2026 | 883 | 194,309 (0%) | 0% | 99.7 | 88,000 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 50,000 | 25,000 | - | - | Performance Restricted Stock Units | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 50,000 | 235,294 (0%) | 0% | - | Common Stock | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 91.98 per share. | 15 Mar 2026 | 40,985 | 194,309 (0%) | 0% | 92.0 | 3,769,714 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 25,000 | 185,294 (0%) | 0% | - | Common Stock | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 25,000 | 0 | - | - | Performance Restricted Stock Units | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 103.30 per share. | 02 Feb 2026 | 9,108 | 160,294 (0%) | 0% | 103.3 | 940,888 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 75,000 | 75,000 | - | - | Performance Restricted Stock Units | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 67,000 | 67,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 43,500 | 43,500 | - | - | Restricted Stock Units | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2026 | 12,500 | 12,500 | - | - | Restricted Stock Units | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2026 | 12,500 | 176,233 (0%) | 0% | - | Common Stock | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 96.19 per share. | 23 Jan 2026 | 6,831 | 169,402 (0%) | 0% | 96.2 | 657,088 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2026 | 12,797 | 25,593 | - | - | Restricted Stock Units | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2026 | 12,797 | 170,831 (0%) | 0% | - | Common Stock | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 93.33 per share. | 21 Jan 2026 | 7,098 | 163,733 (0%) | 0% | 93.3 | 662,422 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 21,070 | 187,500 (0%) | 0% | 0 | Common Stock | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 19,133 | 150,867 | - | - | Employee Stock Option (right to buy) | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.24 per share. | 18 Nov 2025 | 19,133 | 158,034 (0%) | 0% | 19.2 | 368,119 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 11 Aug 2025 | 40,000 | 178,641 (0%) | 0% | 2.9 | 117,440 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 40,000 | 158,487 | - | - | Employee Stock Option (right to buy) | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 62.00 per share. | 11 Aug 2025 | 40,000 | 138,641 (0%) | 0% | 62 | 2,480,000 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 55.25 per share. | 07 Aug 2025 | 40,000 | 138,641 (0%) | 0% | 55.3 | 2,210,040 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 07 Aug 2025 | 40,000 | 178,641 (0%) | 0% | 2.9 | 117,440 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2025 | 40,000 | 198,487 | - | - | Employee Stock Option (right to buy) | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 50,000 | 25,000 | - | - | Performance Restricted Stock Units | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 50,000 | 165,920 (0%) | 0% | - | Common Stock | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 44.21 per share. | 15 Mar 2025 | 27,279 | 138,641 (0%) | 0% | 44.2 | 1,206,122 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 03 Mar 2025 | 40,000 | 155,920 (0%) | 0% | 2.9 | 117,440 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 40,000 | 238,487 | - | - | Employee Stock Option (right to buy) | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 47.19 per share. | 03 Mar 2025 | 20,608 | 115,920 (0%) | 0% | 47.2 | 972,492 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 46.61 per share. | 03 Mar 2025 | 19,392 | 136,528 (0%) | 0% | 46.6 | 903,861 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 48.22 per share. | 03 Feb 2025 | 9,102 | 115,920 (0%) | 0% | 48.2 | 438,921 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2025 | 12,500 | 25,000 | - | - | Restricted Stock Units | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2025 | 12,500 | 131,859 (0%) | 0% | - | Common Stock | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 47.92 per share. | 23 Jan 2025 | 6,837 | 125,022 (0%) | 0% | 47.9 | 327,658 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 153,550 | 153,550 | - | - | Stock Option (right to buy) | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 75,000 | 75,000 | - | - | Performance Restricted Stock Units | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 38,390 | 38,390 | - | - | Restricted Stock Units | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 42.82 per share. | 07 Jan 2025 | 7,489 | 119,359 (0%) | 0% | 42.8 | 320,644 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 21.05 per share. | 08 Nov 2024 | 65 | 126,848 (0%) | 0% | 21.0 | 1,368 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2024 | 34,013 | 278,487 | - | - | Stock Option (right to buy) | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 23 Jul 2024 | 34,013 | 126,783 (0%) | 0% | 2.9 | 99,862 | Common Stock |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 17,500 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 10,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 10,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 1,900 | 0 (0%) | 0% | - | Common Stock | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 21.05 per share. | 10 May 2024 | 817 | 92,770 (0%) | 0% | 21.0 | 17,195 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 26.19 per share. | 02 Feb 2024 | 6,013 | 104,112 (0%) | 0% | 26.2 | 157,491 | Common Stock |
| Mirum Pharma Inc | Peetz Christopher | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharma Inc | Peetz Christopher | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 37,500 | 37,500 | - | - | Restricted Stock Units | |
| Mirum Pharma Inc | Christopher Peetz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 28.03 per share. | 08 Jan 2024 | 5,209 | 110,125 (0%) | 0% | 28.0 | 146,033 | Common Stock |
| Alpine Immune Sciences Inc | Peetz Christopher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 17,500 | 17,500 | - | - | Stock Option (Right to buy) | |
| Mirum Pharma Inc | Christopher Peetz | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.65 per share. | 03 Jul 2023 | 5,498 | 115,334 (0%) | 0% | 25.6 | 141,005 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 16.92 per share. | 10 May 2023 | 1,256 | 120,832 (0%) | 0% | 16.9 | 21,256 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharma Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 50,000 | 119,576 (0%) | 0% | 0 | Common Stock | |
| Mirum Pharma Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 20.62 per share. | 09 Jan 2023 | 5,159 | 91,953 (0%) | 0% | 20.6 | 106,390 | Common Stock |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to buy) | |
| Mirum Pharma Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 17.04 per share. | 10 Nov 2022 | 49 | 69,576 (0%) | 0% | 17.0 | 835 | Common Stock |
| Mirum Pharma Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 13.57 per share. | 10 May 2022 | 1,500 | 69,527 (0%) | 0% | 13.6 | 20,349 | Common STock |
| Mirum Pharma Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 240,000 | 240,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharma Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 40,000 | 68,027 (0%) | 0% | 0 | Common Stock | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to buy) | |
| Mirum Pharma Inc | Christopher Peetz | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 14.40 per share. | 24 Nov 2021 | 7,000 | 28,027 (0%) | 0% | 14.4 | 100,800 | Common Stock |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Purchase of securities on an exchange or from another person at price $ 10.17 per share. | 23 Sep 2021 | 1,900 | 1,900 (0%) | 0% | 10.2 | 19,323 | Common Stock |